HLS Therapeutics Inc. (TSX:HLS)
Canada · Delayed Price · Currency is CAD 3.830
-0.090 (-2.30%)
Aug 11, 2026, 3:59 PM EST
HLS Therapeutics Market Cap
HLS Therapeutics has a market cap or net worth of CAD 119.78 million as of August 12, 2026. Its market cap has decreased by -24.15% in one year.
Market Cap
119.78M
Enterprise Value
163.90M
Revenue
77.81M
Ranking
n/a
PE Ratio
n/a
Stock Price
3.83
ChartMarket Cap Chart
Since March 15, 2018, HLS Therapeutics's market cap has decreased from 317.91M to 119.78M, a decrease of -62.32%. That is a compound annual growth rate of -10.95%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 11, 2026 | 119.78M | -20.54% |
| Dec 31, 2025 | 150.74M | 20.64% |
| Dec 31, 2024 | 124.95M | -1.37% |
| Dec 29, 2023 | 126.68M | -60.20% |
| Dec 30, 2022 | 318.33M | -34.60% |
| Dec 31, 2021 | 486.77M | -14.81% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2018 | Upgrade Pro | Upgrade Pro |
| Mar 15, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Cardiol Therapeutics | 237.46M |
| TerrAscend | 225.98M |
| Organigram Global | 201.31M |
| Cannara Biotech | 189.66M |
| BioSyent | 171.57M |
| Medexus Pharmaceuticals | 157.04M |
| Grown Rogue International | 154.96M |
| Ascend Wellness Holdings | 113.15M |